Support the immune system to fight infectious diseases
These approaches have led to significant weight loss with the dual GLP-1/glucagon receptor agonist survodutide (-13.5% with the 6-mg dose at 76 weeks in a phase 3 SYNCHRONIZE-1 trial) [16] , the dual GLP-1 receptor agonist and GIP antagonist Maridebart cafraglutide (known as MariTide) (-12.3% to -16.2% across different doses at 52 weeks in a phase 2 trial) [17] or the triple GLP-1/GIP/glucagon receptor agonist retatrutide (-24.2% with the 12-mg dose at 48 weeks in a phase 2 trial) [18]
However, the specific mechanism of the FGF5 gene in the development of hair follicles is unclear, and whether it has other effects besides promoting changes in the follicular cycle is currently elusive
Smirnov D, Eremenko E, Stein D, et al
Testosterone, the key male hormone, affects everything from muscle mass and bone density to libido and mood
Published preclinical studies used intraperitoneal injection in rodents, which bypasses the subcutaneous absorption variability human protocols face